The greatest efficacy is reported to occur within the first six months of treatment initiation [11], and normalization of prolactin and tumour volume reduction exceeding 25% within the first 3 months of treatment is predictive of long-term response [12,13]. The gene discussed is PRL; the disease is neoplasm.